Regimen comprising GLP?1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre?mixed insulin regimen. �
Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study.
Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages. Front.
Impact of Carbohydrate on Glucose Variability in Patients with Type 1 Diabetes Assessed Through Professional Continuous Glucose Monitoring: A Retrospective Study.
Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study.
Computer-aided Diagnostic Technique in 2-Deoxy-2-[18F] Fluoro-D-Glucose-Positive Thyroid Nodule: Clinical Experience of 74 Non-thyroid Cancer Patients.
